Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease
Abstract Because of the emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different regions of the world, the battle with infectious coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been seesawing. Therefore, the identification of antiviral drugs is of...
Main Authors: | Dongsheng Li, Gangan Yan, Wenwen Zhou, Shuyi Si, Xiaoping Liu, Jing Zhang, Yan Li, Yunyu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-022-00806-6 |
Similar Items
-
Thermal Stability of Ginkgolic Acids and Thermal Decomposition Kinetics of Ginkgolic Acid C15:1
by: Yuanyuan LI, et al.
Published: (2022-07-01) -
Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy
by: Yuan Ding, et al.
Published: (2022-11-01) -
Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice
by: Maimoona S. Bhutta, et al.
Published: (2021-01-01) -
Ginkgolic acid promotes inflammation and macrophage apoptosis via SUMOylation and NF-κB pathways in sepsis
by: Xinyong Liu, et al.
Published: (2023-01-01) -
Ginkgolic Acid Inhibits Coronavirus Strain 229E Infection of Human Epithelial Lung Cells
by: Maimoona S. Bhutta, et al.
Published: (2021-09-01)